Our study is the first report that indicates Sirt3 might be the downstream target and a novel aspect explaining the beneficial and clinically relevant PPAR-γ effectively in improving neurodegenerative and inflammatory processes during stroke. The gene discussed is PPARG; the disease is Stroke.